Pharmathen Overview

  • Founded
  • 1969
Founded
  • Status
  • Private
  • Employees
  • 1,184
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • (Announced)
  • Financing Rounds
  • 7

Pharmathen General Information

Description

Developer of generic drugs. The company operates as a research-centered, pharmaceutical company that manufactures products like sublingual tablets, hard capsules, eye drops and ophthalmic solutions and more, thereby helping to solve unmet patient needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Primary Office
  • 9, Van Heuven Goedhartlaan
  • 1181 LE Amstelveen
  • Netherlands
+31 020 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmathen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmathen‘s full profile, request access.

Request a free trial

Pharmathen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of generic drugs. The company operates as a research-centered, pharmaceutical company that manufactures produc
Pharmaceuticals
Amstelveen, Netherlands
1,184 As of 2021
000.00
0.00 0000-00-00
000000000000

00000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000 000000000
Mumbai, India
00000 As of 0000
00000000

00000000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
000000000000000
Mumbai, India
00000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmathen Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 00000000
00000000 000000000 Corporation Mumbai, India 00000 00000 000000000 00000
000 000000 00000 Private Debt Financed Bresso, Italy 0000 000.00 000000000 000.00
0000000 0000000 Corporation Trevose, PA 000 000000000
00000 000000 Venture Capital-Backed Geleen, Netherlands 000 0000000000 0
You’re viewing 5 of 18 competitors. Get the full list »

Pharmathen Patents

Pharmathen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3856162-A1 Pharmaceutical composition comprising vildagliptin and metformin and method of preparation thereof Pending 25-Sep-2018 0000000000
EP-3846785-A1 Pharmaceutical composition comprising a magnesium oxide salt complex of febuxostat and method for the preparation thereof Pending 07-Sep-2018 0000000000
EP-3843707-A1 Pharmaceutical composition comprising an immunomodulatory agent and method for the preparation thereof Pending 31-Aug-2018 0000000000
EP-3817728-A1 Pharmaceutical composition comprising an iron chelating agent and method for the preparation thereof Pending 03-Jul-2018 0000000000
EP-3810623-A1 A novel process for the preparation of sglt-2 inhibitors Pending 25-Jun-2018 C07H1/00

Pharmathen Executive Team (8)

Name Title Board Seat Contact Info
Dimitris Kadis Group Chief Executive Officer
Evangelos Karavas Chief Scientific Officer & Vice President of the Board of Directors & Research & Industrial Operations
Stelios Spanos Vice President of Sales and Marketing & Director
Diomedes Vassiliou Group Chief Financial Officer
Nikos Stathopoulos Chief Operating Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Pharmathen Board Members (3)

Name Representing Role Since
00000 000000 Pharmathen Board Member 000 0000
000000000 000000 Pharmathen Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Pharmathen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmathen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmathen‘s full profile, request access.

Request a free trial